PHL-SODIUM POLYSTYRENE SULFONATE ORAL SUSPENSION

Canada - French - Health Canada

Buy It Now

Active ingredient:
Polystyrène sulfonate de sodium
Available from:
PHARMEL INC
ATC code:
V03AE01
INN (International Name):
POLYSTYRENE SULPHONATE
Dosage:
250MG
Pharmaceutical form:
Suspension
Composition:
Polystyrène sulfonate de sodium 250MG
Administration route:
Orale
Units in package:
100/500ML
Prescription type:
Prescription
Therapeutic area:
POTASSIUM-REMOVING AGENTS
Product summary:
Numéro de groupe d'ingrédients actifs (GIA) :0108701001; AHFS:
Authorization status:
ANNULÉ APRÈS COMMERCIALISATION
Authorization number:
02261650
Authorization date:
2010-11-25

Similar products

Search alerts related to this product

Share this information